Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.355
-0.035 (-0.80%)
At close: Aug 26, 2026, 4:00 PM EDT
4.355
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:10 PM EDT
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Bicycle Therapeutics stock has a consensus rating of "Buy" and an average price target of $9.50. The average 1-year stock price forecast is 118.14% higher than the current stock price, while the lowest is $5.00 (+14.81%) and the highest is $14 (+221.47%).
Price Target: $9.50 (+118.14%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bicycle Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 17, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $36 → $11 | Buy | Initiates | $36 → $11 | +152.58% | Jul 31, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $7 | Hold | Maintains | $7 | +60.73% | Jul 31, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 31, 2026 |
| Needham | Needham | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +221.47% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
17.53M
from 72.59M
Decreased by -75.84%
Revenue Next Year
6.69M
from 17.53M
Decreased by -61.85%
EPS This Year
-2.45
from -3.16
EPS Next Year
-2.22
from -2.45
EPS and Forward PE are based on non-GAAP adjusted numbers.